XWAR
MWT
Market cap1mUSD
Oct 09, Last price
2.68PLN
1D
3.08%
1Q
-2.19%
Jan 2017
-74.35%
IPO
-43.10%
Name
MW Trade SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
M.W. Trade SA is a company that specializes in providing financial services to the healthcare sector, operating both within Poland and internationally. The firm offers a variety of financial solutions for hospitals, including a dedicated fund to help resolve debt and liquidity problems, as well as providing immediate funding for short-term cash flow needs related to ongoing operations or investment projects. Additionally, it provides a comprehensive suite of banking products, such as current accounts, working capital loans, investment credit, leasing, bank deposits, and specialized banking and investment options for healthcare employees. Healthcare suppliers can also access financial support from M.W. Trade, covering transaction security, investment financing, and general banking services. Beyond hospitals and suppliers, its client base includes pharmaceutical companies, medical equipment manufacturers, and other local enterprises. Founded in 2004, M.W. Trade SA is based in Wroclaw, Poland, and functions as a subsidiary of Getin Holding SA.
Key people
President of the Management Board · since 2022
Vice President of the Management Board · since 2022
Marek Zalesny
Vice President of the Management Board · since 2024
Iwona Bednarska
Chief Accounting Officer
Tomasz Maczka
Member of the Supervisory Board · since 2025
Krzysztof Piontek
Member of the Supervisory Board · since 2025
Dawid Sukacz
Member of the Supervisory Board · since 2025
Bogdan Wasilewski
Member of the Supervisory Board · since 2025
Ireneusz Wasowicz
Member of the Supervisory Board · since 2025
Headquarters & legal address
WROCŁAW POWSTAŃCÓW ŚLĄSKICH 125/200
WROCŁAW, 02 53-317
PL
WROCŁAW, 02 53-317
PL
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||